Concepts (342)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 26 | 2022 | 327 | 4.670 |
Why?
|
| Thrombosis | 20 | 2023 | 519 | 3.460 |
Why?
|
| Venules | 9 | 2022 | 25 | 2.000 |
Why?
|
| Neutrophils | 9 | 2021 | 381 | 1.550 |
Why?
|
| von Willebrand Factor | 6 | 2024 | 196 | 1.480 |
Why?
|
| Histones | 3 | 2022 | 526 | 1.340 |
Why?
|
| von Willebrand Diseases | 2 | 2022 | 51 | 1.250 |
Why?
|
| Cornea | 10 | 2024 | 654 | 1.110 |
Why?
|
| Fluorescent Dyes | 5 | 2018 | 261 | 1.060 |
Why?
|
| Endotoxemia | 4 | 2012 | 58 | 1.060 |
Why?
|
| Epithelium, Corneal | 8 | 2024 | 173 | 0.990 |
Why?
|
| Microcirculation | 6 | 2021 | 94 | 0.970 |
Why?
|
| Capillary Permeability | 9 | 2005 | 75 | 0.920 |
Why?
|
| Endothelium, Vascular | 7 | 2020 | 520 | 0.890 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2022 | 143 | 0.870 |
Why?
|
| Corneal Injuries | 6 | 2023 | 28 | 0.840 |
Why?
|
| Vasculitis | 2 | 2021 | 49 | 0.830 |
Why?
|
| Platelet Aggregation | 9 | 2016 | 120 | 0.800 |
Why?
|
| CD18 Antigens | 2 | 2021 | 49 | 0.800 |
Why?
|
| P-Selectin | 7 | 2015 | 78 | 0.790 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2021 | 9 | 0.750 |
Why?
|
| Hyperemia | 1 | 2021 | 27 | 0.750 |
Why?
|
| Cell Degranulation | 1 | 2021 | 29 | 0.740 |
Why?
|
| Erythrocytes | 2 | 2021 | 212 | 0.740 |
Why?
|
| Nitric Oxide Synthase | 5 | 2007 | 186 | 0.730 |
Why?
|
| Animals | 55 | 2025 | 34067 | 0.720 |
Why?
|
| Mast Cells | 1 | 2021 | 74 | 0.720 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2024 | 153 | 0.670 |
Why?
|
| Mice | 39 | 2025 | 17627 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 22 | 2024 | 4402 | 0.630 |
Why?
|
| Intravital Microscopy | 1 | 2018 | 16 | 0.600 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 579 | 0.580 |
Why?
|
| Microvessels | 2 | 2020 | 56 | 0.560 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2025 | 536 | 0.550 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2002 | 59 | 0.530 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.530 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2015 | 2 | 0.510 |
Why?
|
| Platelet Activation | 5 | 2020 | 71 | 0.510 |
Why?
|
| Neutrophil Activation | 2 | 2005 | 16 | 0.500 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 380 | 0.500 |
Why?
|
| Antithrombin III | 1 | 2015 | 25 | 0.500 |
Why?
|
| Nitric Oxide | 3 | 2007 | 445 | 0.490 |
Why?
|
| Sepsis | 3 | 2010 | 478 | 0.480 |
Why?
|
| Wound Healing | 8 | 2021 | 436 | 0.470 |
Why?
|
| Inflammation | 6 | 2022 | 1428 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 356 | 0.470 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 370 | 0.460 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 141 | 0.460 |
Why?
|
| Diet, High-Fat | 5 | 2024 | 212 | 0.460 |
Why?
|
| Acetaminophen | 1 | 2015 | 94 | 0.460 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 107 | 0.460 |
Why?
|
| Hepatocytes | 1 | 2015 | 208 | 0.450 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2023 | 61 | 0.440 |
Why?
|
| Serum Albumin | 1 | 2013 | 110 | 0.410 |
Why?
|
| Fibrin | 4 | 2024 | 64 | 0.380 |
Why?
|
| Obesity | 6 | 2024 | 2262 | 0.370 |
Why?
|
| Collagen | 4 | 2023 | 315 | 0.350 |
Why?
|
| Muscle, Skeletal | 3 | 2005 | 942 | 0.330 |
Why?
|
| Hemostasis | 3 | 2019 | 69 | 0.320 |
Why?
|
| Cell Movement | 6 | 2021 | 835 | 0.310 |
Why?
|
| Enzyme Inhibitors | 3 | 2002 | 578 | 0.310 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 409 | 0.300 |
Why?
|
| Serum Albumin, Bovine | 4 | 2003 | 48 | 0.300 |
Why?
|
| Mice, Knockout | 13 | 2019 | 3727 | 0.290 |
Why?
|
| Electromagnetic Fields | 1 | 2007 | 26 | 0.290 |
Why?
|
| Capillaries | 2 | 2005 | 66 | 0.280 |
Why?
|
| Cell Communication | 2 | 2005 | 165 | 0.280 |
Why?
|
| Endothelial Cells | 1 | 2010 | 521 | 0.280 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2007 | 60 | 0.280 |
Why?
|
| Dyslipidemias | 2 | 2020 | 232 | 0.270 |
Why?
|
| Edema | 1 | 2007 | 135 | 0.270 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 238 | 0.260 |
Why?
|
| Male | 28 | 2024 | 61018 | 0.260 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 434 | 0.250 |
Why?
|
| Mitochondria, Muscle | 1 | 2005 | 34 | 0.250 |
Why?
|
| Rats | 8 | 2007 | 3676 | 0.250 |
Why?
|
| Endotoxins | 1 | 2005 | 48 | 0.250 |
Why?
|
| Phagocytosis | 3 | 2024 | 171 | 0.240 |
Why?
|
| Mesentery | 2 | 2002 | 28 | 0.240 |
Why?
|
| Albumins | 2 | 2002 | 87 | 0.240 |
Why?
|
| Arterioles | 1 | 2005 | 28 | 0.240 |
Why?
|
| Oculomotor Muscles | 1 | 2005 | 64 | 0.240 |
Why?
|
| Muscle Contraction | 1 | 2005 | 188 | 0.240 |
Why?
|
| Megakaryocytes | 1 | 2025 | 42 | 0.240 |
Why?
|
| omega-N-Methylarginine | 2 | 2002 | 12 | 0.230 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 4344 | 0.230 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 221 | 0.230 |
Why?
|
| Calcium | 2 | 2007 | 1100 | 0.230 |
Why?
|
| Cardiolipins | 1 | 2024 | 18 | 0.220 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 180 | 0.220 |
Why?
|
| Leukocytes | 4 | 2020 | 204 | 0.220 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2024 | 26 | 0.220 |
Why?
|
| Secretory Vesicles | 3 | 2019 | 19 | 0.220 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 136 | 0.220 |
Why?
|
| Pandemics | 2 | 2022 | 1096 | 0.220 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 181 | 0.220 |
Why?
|
| Corneal Stroma | 1 | 2024 | 91 | 0.210 |
Why?
|
| Models, Animal | 2 | 2021 | 461 | 0.210 |
Why?
|
| Lipopolysaccharides | 3 | 2012 | 292 | 0.210 |
Why?
|
| Light | 2 | 2004 | 176 | 0.210 |
Why?
|
| Sucrose | 1 | 2023 | 39 | 0.210 |
Why?
|
| Humans | 26 | 2024 | 124227 | 0.200 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2022 | 39 | 0.200 |
Why?
|
| Hemostatics | 1 | 2022 | 57 | 0.200 |
Why?
|
| Exocytosis | 2 | 2019 | 63 | 0.190 |
Why?
|
| Fluorescein-5-isothiocyanate | 4 | 2003 | 29 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2005 | 1231 | 0.190 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 101 | 0.190 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2021 | 61 | 0.180 |
Why?
|
| Macrophages | 2 | 2024 | 615 | 0.180 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 394 | 0.180 |
Why?
|
| Meibomian Glands | 1 | 2020 | 43 | 0.180 |
Why?
|
| Hypertrophy | 1 | 2020 | 102 | 0.180 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 2011 | 137 | 0.170 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2020 | 67 | 0.170 |
Why?
|
| Face | 1 | 2021 | 179 | 0.160 |
Why?
|
| Splanchnic Circulation | 4 | 2002 | 53 | 0.160 |
Why?
|
| Catalytic Domain | 3 | 2023 | 158 | 0.160 |
Why?
|
| Regeneration | 1 | 2021 | 197 | 0.160 |
Why?
|
| Tears | 1 | 2020 | 172 | 0.160 |
Why?
|
| Ischemia | 1 | 2002 | 354 | 0.160 |
Why?
|
| Munc18 Proteins | 1 | 2019 | 20 | 0.160 |
Why?
|
| Phosphatidylserines | 3 | 2013 | 47 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2020 | 222 | 0.150 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 338 | 0.150 |
Why?
|
| Fibrinogen | 4 | 2023 | 154 | 0.150 |
Why?
|
| Cytokines | 2 | 2015 | 1289 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2025 | 1888 | 0.140 |
Why?
|
| Staining and Labeling | 1 | 2018 | 186 | 0.140 |
Why?
|
| Proteins | 1 | 2003 | 1036 | 0.140 |
Why?
|
| Actins | 2 | 2016 | 341 | 0.140 |
Why?
|
| Protein Phosphatase 1 | 2 | 2023 | 51 | 0.140 |
Why?
|
| Antibodies | 1 | 2018 | 373 | 0.130 |
Why?
|
| Thrombin | 3 | 2013 | 59 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2021 | 711 | 0.130 |
Why?
|
| Hypersensitivity | 1 | 2018 | 183 | 0.130 |
Why?
|
| Platelet Function Tests | 2 | 2013 | 40 | 0.120 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 11 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2011 | 29 | 0.120 |
Why?
|
| Corneal Keratocytes | 1 | 2015 | 4 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 84 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 37 | 0.120 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2015 | 55 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 135 | 0.120 |
Why?
|
| Conscious Sedation | 1 | 2015 | 62 | 0.120 |
Why?
|
| Gene Expression | 2 | 2012 | 1561 | 0.120 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 273 | 0.120 |
Why?
|
| Platelet Storage Pool Deficiency | 1 | 1994 | 2 | 0.110 |
Why?
|
| Calcineurin | 1 | 2014 | 101 | 0.110 |
Why?
|
| Anesthesia, General | 1 | 2015 | 118 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 53 | 0.110 |
Why?
|
| Blood Coagulation | 2 | 2016 | 123 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2015 | 381 | 0.100 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1994 | 142 | 0.100 |
Why?
|
| Diet | 1 | 2019 | 1136 | 0.100 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 30 | 0.100 |
Why?
|
| Xanthenes | 2 | 2002 | 7 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2014 | 4503 | 0.090 |
Why?
|
| Research Design | 2 | 2007 | 689 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 2010 | 69 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 222 | 0.090 |
Why?
|
| Heart Valve Prosthesis | 1 | 1994 | 301 | 0.090 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 61 | 0.090 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 78 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1533 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2012 | 3038 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2011 | 119 | 0.090 |
Why?
|
| Cell Separation | 1 | 2010 | 227 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 1708 | 0.080 |
Why?
|
| Neurons | 1 | 2019 | 1957 | 0.080 |
Why?
|
| Rana pipiens | 2 | 2002 | 37 | 0.080 |
Why?
|
| Time Factors | 3 | 2021 | 6275 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 970 | 0.080 |
Why?
|
| Complement C3 | 1 | 2009 | 48 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2023 | 406 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 409 | 0.080 |
Why?
|
| Arginine | 3 | 2005 | 332 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2008 | 119 | 0.080 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2008 | 8 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2021 | 461 | 0.070 |
Why?
|
| Perfusion | 2 | 2002 | 201 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2008 | 52 | 0.070 |
Why?
|
| Carrageenan | 1 | 2007 | 4 | 0.070 |
Why?
|
| Platelet Adhesiveness | 1 | 2008 | 40 | 0.070 |
Why?
|
| Swine | 2 | 2002 | 1177 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 64 | 0.070 |
Why?
|
| Shear Strength | 1 | 2007 | 17 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 275 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 52 | 0.070 |
Why?
|
| Histamine | 1 | 2007 | 44 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2010 | 232 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1688 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2011 | 909 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1022 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 196 | 0.060 |
Why?
|
| Chlorophenols | 1 | 2005 | 1 | 0.060 |
Why?
|
| Citrate (si)-Synthase | 1 | 2005 | 17 | 0.060 |
Why?
|
| Calcimycin | 1 | 2005 | 26 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2005 | 38 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2008 | 461 | 0.060 |
Why?
|
| Keratitis | 1 | 2006 | 116 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 1 | 2005 | 38 | 0.060 |
Why?
|
| Heparin | 1 | 2007 | 227 | 0.060 |
Why?
|
| Female | 7 | 2021 | 66301 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 95 | 0.060 |
Why?
|
| Caffeine | 1 | 2005 | 70 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2005 | 150 | 0.060 |
Why?
|
| von Willebrand Disease, Type 3 | 1 | 2024 | 6 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2007 | 646 | 0.060 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2024 | 11 | 0.060 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2024 | 19 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2004 | 79 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 167 | 0.050 |
Why?
|
| Adult | 4 | 2015 | 29367 | 0.050 |
Why?
|
| Isoelectric Point | 1 | 2003 | 18 | 0.050 |
Why?
|
| Lactalbumin | 1 | 2003 | 11 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2025 | 338 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 22 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2003 | 390 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1284 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2022 | 88 | 0.050 |
Why?
|
| Mineral Oil | 1 | 2002 | 4 | 0.050 |
Why?
|
| Emollients | 1 | 2002 | 2 | 0.050 |
Why?
|
| Lymph | 1 | 2002 | 25 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 66 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 105 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2007 | 589 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2021 | 48 | 0.050 |
Why?
|
| Intra-Abdominal Fat | 1 | 2021 | 51 | 0.050 |
Why?
|
| Biological Transport | 1 | 2002 | 354 | 0.050 |
Why?
|
| Species Specificity | 1 | 2002 | 549 | 0.050 |
Why?
|
| Binding Sites | 1 | 2024 | 1295 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2014 | 744 | 0.050 |
Why?
|
| Research | 1 | 2003 | 263 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2020 | 15 | 0.050 |
Why?
|
| Cholesterol Esters | 1 | 2020 | 15 | 0.040 |
Why?
|
| Anura | 1 | 2000 | 13 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 73 | 0.040 |
Why?
|
| Bradykinin | 1 | 2000 | 59 | 0.040 |
Why?
|
| Ceramides | 1 | 2020 | 38 | 0.040 |
Why?
|
| Cicatrix | 1 | 2021 | 122 | 0.040 |
Why?
|
| Epididymis | 1 | 2020 | 55 | 0.040 |
Why?
|
| Neoplasms | 1 | 2015 | 2763 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2015 | 6121 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 314 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 142 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2000 | 205 | 0.040 |
Why?
|
| Cell Fusion | 1 | 2019 | 37 | 0.040 |
Why?
|
| Photochemistry | 1 | 1999 | 22 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2014 | 1615 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2014 | 797 | 0.040 |
Why?
|
| Histidine | 1 | 1999 | 73 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 2883 | 0.040 |
Why?
|
| Arteries | 1 | 2000 | 221 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2815 | 0.040 |
Why?
|
| Hemolysis | 1 | 1999 | 112 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2025 | 1002 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 357 | 0.040 |
Why?
|
| Critical Illness | 1 | 2022 | 603 | 0.040 |
Why?
|
| Triglycerides | 1 | 2020 | 574 | 0.040 |
Why?
|
| Body Composition | 1 | 2020 | 522 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 1166 | 0.030 |
Why?
|
| Talin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 383 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 298 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 685 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 457 | 0.030 |
Why?
|
| Heart | 1 | 2000 | 708 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2005 | 2582 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 1689 | 0.030 |
Why?
|
| Endosonography | 1 | 2015 | 79 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2014 | 36 | 0.030 |
Why?
|
| Chlorides | 1 | 2014 | 106 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 116 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2013 | 9 | 0.030 |
Why?
|
| Cofilin 1 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 324 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 150 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 89 | 0.030 |
Why?
|
| Syk Kinase | 1 | 2012 | 12 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 19 | 0.030 |
Why?
|
| Pyridines | 1 | 2013 | 229 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1996 | 384 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1996 | 366 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2015 | 791 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 209 | 0.020 |
Why?
|
| Endocytosis | 1 | 2012 | 125 | 0.020 |
Why?
|
| Middle Aged | 2 | 2015 | 26605 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 419 | 0.020 |
Why?
|
| Vasodilation | 2 | 2005 | 190 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 325 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2009 | 12 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 41 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2041 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 57 | 0.020 |
Why?
|
| Surface Properties | 1 | 2010 | 81 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 555 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 63 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 122 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2009 | 8 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 229 | 0.020 |
Why?
|
| Phenanthrenes | 1 | 2008 | 5 | 0.020 |
Why?
|
| Maleimides | 1 | 2008 | 11 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2392 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 822 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3049 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2008 | 32 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2008 | 63 | 0.020 |
Why?
|
| Milk Proteins | 1 | 2008 | 92 | 0.020 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2008 | 8 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 25 | 0.020 |
Why?
|
| Spleen | 1 | 2008 | 281 | 0.020 |
Why?
|
| CD11a Antigen | 1 | 2007 | 10 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 26 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 485 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 106 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 362 | 0.020 |
Why?
|
| Pterins | 1 | 2005 | 6 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 326 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2005 | 14 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 31 | 0.020 |
Why?
|
| Homocysteine | 1 | 2005 | 122 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 137 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 4252 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2012 | 911 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2006 | 221 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 219 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1455 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 256 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 622 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6465 | 0.010 |
Why?
|
| Antioxidants | 1 | 2005 | 335 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1784 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 527 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 19545 | 0.010 |
Why?
|
| Ascites | 1 | 1996 | 88 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1996 | 121 | 0.010 |
Why?
|
| Hypoxia | 1 | 1996 | 248 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1996 | 251 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 1118 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1996 | 436 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1996 | 831 | 0.000 |
Why?
|